ASCA-101
N/A
Report date: 2025/07/23 11:38:27
NME
Base Information
Drug NameASCA-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMetafines Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesMetafines Co LtdBMI Korea Co Ltd
Inactive CompaniesN/A
Active Indications +[8]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A